SOLIGENIX, INC. Income Tax Expense
SOLIGENIX, INC. (SNGX) reported Income Tax Expense of -$506.62 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-03-31
- SOLIGENIX, INC. income tax expense (benefit) for the quarter ending 2023-12-31 was -$606.61K.
- SOLIGENIX, INC. income tax expense (benefit) for the quarter ending 2023-09-30 was $0.00.
- SOLIGENIX, INC. income tax expense (benefit) for the quarter ending 2023-06-30 was $0.00.
- SOLIGENIX, INC. income tax expense (benefit) for the quarter ending 2023-03-31 was -$1.16M.
- SOLIGENIX, INC. income tax expense (benefit) for fiscal 2025 was -$506.62K.
- SOLIGENIX, INC. income tax expense (benefit) for fiscal 2024 was -$409.11K.
- SOLIGENIX, INC. income tax expense (benefit) for fiscal 2023 was -$1.77M.
- SOLIGENIX, INC. income tax expense (benefit) for fiscal 2022 was -$1.15M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$506.62K 10-K · filed 2026-03-31 | |||
| 2024-12-31 | -$409.11K 10-K · filed 2026-03-31 | |||
| 2023-12-31 | -$606.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$606.61K derived: sum of 2 quarters · filed 2025-03-21 | -$606.61K derived: sum of 3 quarters · filed 2025-03-21 | -$1.77M 10-K · filed 2025-03-21 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | -$1.16M 10-Q · filed 2024-11-08 | -$1.16M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.16M 10-Q · filed 2024-08-09 | -$1.16M derived: sum of 3 quarters · filed 2024-08-09 | -$2.32M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | -$1.16M 10-Q · filed 2024-05-10 | -$1.16M derived: sum of 2 quarters · filed 2024-05-10 | -$2.32M derived: sum of 3 quarters · filed 2024-05-10 | -$3.47M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$1.15M derived: sum of 2 quarters · filed 2024-03-15 | -$2.31M derived: sum of 3 quarters · filed 2024-03-15 | -$1.15M 10-K · filed 2024-03-15 |
| 2022-09-30 | -$1.15M 10-Q · filed 2022-11-10 | -$2.31M derived: sum of 2 quarters · filed 2023-08-21 | -$1.15M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$1.15M 10-Q · filed 2023-08-21 | -$1.15M 10-Q · filed 2023-08-21 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$864.74K derived: sum of 2 quarters · filed 2023-03-31 | -$1.73M derived: sum of 3 quarters · filed 2023-03-31 | -$864.74K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$864.74K 10-Q · filed 2022-11-10 | -$1.73M derived: sum of 2 quarters · filed 2022-11-10 | -$864.74K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$864.74K 10-Q · filed 2022-08-12 | -$864.74K 10-Q · filed 2022-08-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $0.00 derived: sum of 3 quarters · filed 2022-03-29 | -$836.89K 10-K · filed 2022-03-29 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-11-12 | -$836.89K 10-Q · filed 2021-11-12 | -$836.89K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$836.89K 10-Q · filed 2021-08-13 | -$836.89K derived: sum of 3 quarters · filed 2021-08-13 | -$836.89K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$836.89K 10-Q · filed 2021-05-18 | -$836.89K derived: sum of 2 quarters · filed 2021-05-18 | -$836.89K derived: sum of 3 quarters · filed 2021-05-18 | -$836.89K derived: sum of 4 quarters · filed 2021-05-18 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | -$610.68K 10-K · filed 2021-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | -$610.68K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$610.68K 10-Q · filed 2020-08-14 | ||
| 2019-03-31 | -$610.68K 10-Q · filed 2020-05-15 | |||
| 2017-12-31 | -$416.81K 10-K · filed 2019-03-26 | |||
| 2016-12-31 | -$530.14K 10-K · filed 2018-03-15 | |||
| 2015-12-31 | -$488.93K 10-K · filed 2017-03-27 | |||
| 2014-12-31 | -$616.87K 10-K · filed 2016-03-24 | |||
| 2013-12-31 | -$750.36K 10-K · filed 2015-03-25 | |||
| 2012-12-31 | -$521.46K 10-K · filed 2014-03-26 | |||
| 2011-12-31 | -$574.16K 10-K · filed 2013-02-26 | |||
| 2010-12-31 | -$245.81K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |